Insilico Medicine, a clinical-stage drug development technology company driven by generative artificial intelligence (AI), has announced its inclusion in the...
-
-
Recent Updates
- Moonshot AI Firm Files for Hong Kong IPO, Eyes $3 Billion Raise
- China’s Emerging Role in Global Pharma Industry
- U.S. Data Center Vulnerabilities Exposed Amid Chinese Power Equipment Reliance
- Chinese AI Firm Moonshot Pursues $3 Billion IPO in Hong Kong
- Dinto Solar Expands HJT Technology Globally in its Ninth Year Journey
- US Imposes Steep Tariffs on Chinese Drone Imports
- US Imposes Steep Tariffs on Chinese Drone Imports
- Dispute Over Key Word Led to China-US Tensions at G20
- Uproar Over CCP-Related Trade Jargon Marks G20 Dispute
- China’s Technological Rise Attracting Foreign Interest
Blogroll